var data={"title":"Esophageal motility disorders: Clinical manifestations, diagnosis, and management","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Esophageal motility disorders: Clinical manifestations, diagnosis, and management</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/contributors\" class=\"contributor contributor_credentials\">Donald O Castell, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/contributors\" class=\"contributor contributor_credentials\">Nicholas J Talley, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/contributors\" class=\"contributor contributor_credentials\">Kristen M Robson, MD, MBA, FACG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 02, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Esophageal motility is considered abnormal if motility findings exceed two standard deviations from those found in a large group of normal subjects [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/1\" class=\"abstract_t\">1</a>]. While the clinical implications of some esophageal motility disorders such as achalasia are clear, there is considerable controversy concerning the clinical implications of other esophageal motility abnormalities found on esophageal manometry testing and whether they cause or explain the patient's symptoms.</p><p>This topic will review the pathophysiology, clinical features, diagnosis, and management of three specific abnormal esophageal motility patterns: diffuse (distal) esophageal spasm (DES), and the hypercontracting esophageal motility disorders of hypertensive peristalsis (nutcracker esophagus) and hypertensive lower esophageal sphincter (LES). The pathophysiology, clinical features, and management of achalasia and the evaluation and management of chest pain of esophageal origin are discussed separately. (See <a href=\"topic.htm?path=pathophysiology-and-etiology-of-achalasia\" class=\"medical medical_review\">&quot;Pathophysiology and etiology of achalasia&quot;</a> and <a href=\"topic.htm?path=achalasia-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Achalasia: Pathogenesis, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=overview-of-the-treatment-of-achalasia\" class=\"medical medical_review\">&quot;Overview of the treatment of achalasia&quot;</a> and <a href=\"topic.htm?path=evaluation-of-the-adult-with-chest-pain-of-esophageal-origin\" class=\"medical medical_review\">&quot;Evaluation of the adult with chest pain of esophageal origin&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">CLASSIFICATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Esophageal motility disorders may occur as isolated phenomena (primary) or associated with other diseases (secondary) (<a href=\"image.htm?imageKey=GAST%2F64858\" class=\"graphic graphic_table graphicRef64858 \">table 1</a> and <a href=\"image.htm?imageKey=GAST%2F75807\" class=\"graphic graphic_table graphicRef75807 \">table 2</a>). Using conventional esophageal manometry, primary esophageal abnormalities are classified as achalasia and other abnormal motility patterns and further subclassified into those with hypercontracting, hypocontracting, or discoordinated motility (<a href=\"image.htm?imageKey=GAST%2F64858\" class=\"graphic graphic_table graphicRef64858 \">table 1</a>).</p><p>Based on high resolution manometry (HRM) with esophageal pressure topography (EPT), esophageal motility disorders are classified according to the Chicago Classification [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/2-4\" class=\"abstract_t\">2-4</a>]. The Chicago Classification divides esophageal motility disorders according to the relaxation of the lower esophageal sphincter (LES), as measured by the integrated relaxation pressure (IRP). Once LES relaxation has been characterized, motility disorders are then further categorized based on abnormalities in esophageal peristalsis. Findings on HRM with EPT largely correlate with findings on conventional manometry (<a href=\"image.htm?imageKey=GAST%2F81969\" class=\"graphic graphic_table graphicRef81969 \">table 3</a>). (See <a href=\"topic.htm?path=high-resolution-manometry#H544147912\" class=\"medical medical_review\">&quot;High resolution manometry&quot;, section on 'Overview'</a>.)</p><p class=\"headingAnchor\" id=\"H2107334865\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are limited data on the prevalence of diffuse (distal) esophageal spasm (DES) and hypercontracting esophageal motility abnormalities (hypertensive peristalsis [nutcracker esophagus] and hypertensive lower esophageal sphincter). In one study that included 1480 individuals referred for esophageal manometry for evaluation of dysphagia or chest pain, the prevalence of manometric findings consistent with DES was 4 percent [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/5\" class=\"abstract_t\">5</a>]. In another study, manometric findings consistent with nutcracker esophagus were noted in 12 percent of patients with unexplained chest pain [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/6\" class=\"abstract_t\">6</a>].</p><p>Some esophageal motility disorders have been associated with specific psychiatric conditions. A study evaluated responses to a psychometric questionnaire in 113 patients with abnormal esophageal motility, 23 symptomatic controls and 27 asymptomatic controls [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/7\" class=\"abstract_t\">7</a>]. As compared with asymptomatic controls, increased somatization, acute anxiety, or depression was noted in patients with hypertensive lower esophageal sphincter (LES), nutcracker esophagus, and hypotensive contractions, but not in patients with DES.</p><p class=\"headingAnchor\" id=\"H2107333572\"><span class=\"h1\">PATHOPHYSIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although the underlying pathology is unknown, diffuse (distal) esophageal spasm (DES) has been associated with an impairment of inhibitory innervation, leading to both premature and rapidly propagated or simultaneous contractions in the distal esophagus. It has also been hypothesized that patients with DES may have a malfunction in endogenous nitric oxide synthesis <span class=\"nowrap\">and/or</span> degradation. This hypothesis is supported by a dose-dependent decrease in the duration of swallow-induced contractions with intravenous glycerine trinitrate and improvement in symptoms with phosphodiesterase inhibitors [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/8\" class=\"abstract_t\">8</a>] and nitrates [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/9-11\" class=\"abstract_t\">9-11</a>]. It is further reinforced by the observation that the normal peristaltic pattern in asymptomatic volunteers will change to a simultaneous (spastic) pattern during administration of a nitric oxide scavenger, with some subjects experiencing chest pain [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/12\" class=\"abstract_t\">12</a>]. Ineffective esophageal transport in patients with DES results in symptoms of dysphagia. (See <a href=\"#H10\" class=\"local\">'Management'</a> below.)</p><p>In contrast with DES, nutcracker esophagus and hypertensive lower esophageal sphincter (LES) are due to overactivity of excitatory innervation or smooth muscle response to excitatory nerves [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/13,14\" class=\"abstract_t\">13,14</a>]. Although hypertensive peristalsis and isolated LES hypertension have been primarily considered to be manometric abnormalities that should not affect esophageal emptying, studies using prolonged ambulatory manometry have found that some patients with hypertensive peristalsis have nonperistaltic contractions during mealtime that result in dysphagia [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/15\" class=\"abstract_t\">15</a>]. Similarly, it is possible that some patients with hypertensive LES have intermittent abnormalities of LES relaxation that result in dysphagia.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CLINICAL FEATURES</span></p><p class=\"headingAnchor\" id=\"H2107334765\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with diffuse (distal) esophageal spasm (DES) are symptomatic and present with dysphagia for solids and liquids. Patients have esophageal dysphagia, which is characterized by difficulty swallowing several seconds after initiating a swallow and a sensation of food getting stuck in the esophagus. The dysphagia may occur in association with retrosternal chest pain. In some cases, patients have symptoms of heartburn or regurgitation. In contrast with DES, only a small proportion of patients with nutcracker esophagus and hypertensive lower esophageal sphincter (LES) are symptomatic. In all three disorders, symptoms do not necessarily correlate with manometric abnormalities and may be due to concurrent gastroesophageal reflux disease (GERD) or heightened visceral sensitivity [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/6,16,17\" class=\"abstract_t\">6,16,17</a>]. (See <a href=\"#H6\" class=\"local\">'Esophageal manometry'</a> below.)</p><p class=\"headingAnchor\" id=\"H2107333021\"><span class=\"h2\">Imaging findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients with nutcracker esophagus and hypertensive LES, <a href=\"topic.htm?path=barium-drug-information\" class=\"drug drug_general\">barium</a> swallow shows normal sequential peristalsis. In patients with DES, severe nonperistaltic contractions may result in a &quot;rosary bead&quot; or &quot;corkscrew&quot; appearance of the esophagus on barium swallow (<a href=\"image.htm?imageKey=GAST%2F69821\" class=\"graphic graphic_diagnosticimage graphicRef69821 \">image 1</a> and <a href=\"image.htm?imageKey=RADIOL%2F93739\" class=\"graphic graphic_diagnosticimage graphicRef93739 \">image 2</a>). However, barium swallow is neither sensitive nor specific for DES. Simultaneous contractions have been reported in patients with diabetes, connective tissue disorders, alcoholism, GERD, and in 10 percent of swallows in healthy subjects [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/18\" class=\"abstract_t\">18</a>]. In one series of 76 patients with DES who had undergone a barium swallow, 46 (57 percent) had nonspecific abnormalities, and only three (4 percent) had a corkscrew appearance [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/19\" class=\"abstract_t\">19</a>].</p><p class=\"headingAnchor\" id=\"H2107332911\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An esophageal motility disorder should be suspected in a patient with esophageal dysphagia, noncardiac chest pain, or refractory gastroesophageal reflux disease (GERD) symptoms (heartburn or regurgitation). The diagnosis of diffuse esophageal spasm (DES), nutcracker esophagus, and hypertensive lower esophageal sphincter (LES) requires the exclusion of other, more common conditions associated with these symptoms and the presence of characteristic abnormalities on esophageal manometry testing. (See <a href=\"#H2188832589\" class=\"local\">'Differential diagnosis'</a> below.)</p><p class=\"headingAnchor\" id=\"H26371848\"><span class=\"h2\">Diagnostic approach</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In patients with esophageal dysphagia, we perform an upper endoscopy and biopsy to rule out other structural esophageal disorders (<a href=\"image.htm?imageKey=GAST%2F81108\" class=\"graphic graphic_algorithm graphicRef81108 \">algorithm 1</a>). (See <a href=\"topic.htm?path=approach-to-the-evaluation-of-dysphagia-in-adults#H2735888503\" class=\"medical medical_review\">&quot;Approach to the evaluation of dysphagia in adults&quot;, section on 'Approach to diagnostic testing'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In patients with noncardiac chest pain or GERD symptoms (heartburn or regurgitation) that are refractory to twice daily proton pump inhibitor (PPI) therapy, we perform esophageal pH and impedance testing (<a href=\"image.htm?imageKey=GAST%2F66387\" class=\"graphic graphic_algorithm graphicRef66387 \">algorithm 2</a> and <a href=\"image.htm?imageKey=GAST%2F70106\" class=\"graphic graphic_algorithm graphicRef70106 \">algorithm 3</a>). (See <a href=\"topic.htm?path=esophageal-multichannel-intraluminal-impedance-testing\" class=\"medical medical_review\">&quot;Esophageal multichannel intraluminal impedance testing&quot;</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>If the above evaluation is negative, we then proceed to esophageal manometry testing to establish the diagnosis of a specific esophageal motility disorder.</p><p/><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Esophageal manometry</span></p><p class=\"headingAnchor\" id=\"H2107333199\"><span class=\"h3\">Diffuse (distal) esophageal spasm</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>DES is characterized by increased simultaneous contractions in the distal esophagus (<a href=\"image.htm?imageKey=GAST%2F82704\" class=\"graphic graphic_figure graphicRef82704 \">figure 1</a>). On conventional manometry, DES is defined by 20 percent or more simultaneous contractions (with amplitude &gt;30 mmHg). On high resolution manometry (HRM) with esophageal pressure topography (EPT), DES is defined by &ge;20 percent premature contractions (distal latency &lt;4.5 seconds). (See <a href=\"topic.htm?path=high-resolution-manometry#H1871924\" class=\"medical medical_review\">&quot;High resolution manometry&quot;, section on 'Distal esophageal spasm (DES)'</a>.)</p><p>It is important to note that DES is intermittent, and manometric findings may be seen with only some of a series of test swallows or only on some days of testing. Patients with DES may also have a variety of other nonspecific manometric findings, including repetitive and prolonged duration contractions [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/20,21\" class=\"abstract_t\">20,21</a>]. Although most patients with DES usually have normal relaxation of the LES, approximately one-third of patients may have high resting pressure or incomplete relaxation [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/22-24\" class=\"abstract_t\">22-24</a>]. Patients with DES who present with chest pain have higher amplitudes and better transit of swallowed boluses on impedance testing as compared with those who present with dysphagia [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/25,26\" class=\"abstract_t\">25,26</a>]. </p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Hypertensive peristalsis (nutcracker esophagus)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nutcracker esophagus is characterized by normal sequential contractions in the smooth muscle esophagus of excessive amplitude or duration. On conventional manometry, nutcracker esophagus is defined by high amplitude peristaltic contractions in the distal 10 cm of the esophagus, with average distal esophageal peristaltic pressures exceeding 220 mmHg after 10 5 mL liquid swallows [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/16\" class=\"abstract_t\">16</a>]. On HRM with EPT, these high pressure contractions are identified by distal contractile integral (DCI) &gt;8000x mmHg&#8729;s&#8729;cm (<a href=\"image.htm?imageKey=GAST%2F67976\" class=\"graphic graphic_figure graphicRef67976 \">figure 2</a>). Other terms for hypertensive peristalsis include &quot;spastic nutcracker&quot; or &quot;jackhammer esophagus&quot; [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/2\" class=\"abstract_t\">2</a>]. (See <a href=\"topic.htm?path=high-resolution-manometry#H1561726\" class=\"medical medical_review\">&quot;High resolution manometry&quot;, section on 'Hypercontractile (jackhammer) esophagus'</a>.)</p><p>Nutcracker esophagus may overlap with other esophageal motility disorders. Many patients with nutcracker esophagus also have a hypertensive or poorly relaxing LES. One study using ambulatory 24-hour esophageal manometry found that patterns of DES or nutcracker esophagus on stationary manometry frequently interchanged during episodes of chest pain [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/15\" class=\"abstract_t\">15</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Hypertensive lower esophageal sphincter</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypertensive LES is defined as a resting, midrespiratory LES pressure greater than 45 mmHg on conventional manometry (<a href=\"image.htm?imageKey=GAST%2F67976\" class=\"graphic graphic_figure graphicRef67976 \">figure 2</a>). On HRM with EPT, hypertensive LES is defined as a pressure greater than 35 mmHg (<a href=\"image.htm?imageKey=GAST%2F59779\" class=\"graphic graphic_table graphicRef59779 \">table 4</a>).</p><p class=\"headingAnchor\" id=\"H2188832589\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of an esophageal motility disorder includes other causes of esophageal dysphagia and chest pain. These include gastroesophageal reflux disease (GERD), esophageal stricture, eosinophilic esophagitis, infectious or radiation esophagitis, esophageal rings and webs. Most of these conditions can be excluded by upper endoscopy with biopsy or esophageal pH and impedance testing. Diffuse (distal) esophageal spasm (DES), nutcracker esophagus, and hypertensive lower esophageal sphincter (LES) can be distinguished from other esophageal motility disorders by esophageal manometry testing. (See <a href=\"#H26371848\" class=\"local\">'Diagnostic approach'</a> above and <a href=\"topic.htm?path=approach-to-the-evaluation-of-dysphagia-in-adults#H3\" class=\"medical medical_review\">&quot;Approach to the evaluation of dysphagia in adults&quot;, section on 'Symptom-based differential diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>While multiple therapies have been used to treat diffuse (distal) esophageal spasm (DES), nutcracker esophagus, and hypertensive lower esophageal sphincter (LES), the most effective treatment has not been defined. This is attributable to the lack of convincing evidence from randomized trials, possibly due to different pathophysiologic mechanisms involved in individual patients and the poor correlation of manometric findings with symptoms.</p><p class=\"headingAnchor\" id=\"H2188831933\"><span class=\"h2\">Initial therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients whose primary symptom is dysphagia, we suggest initial treatment with a calcium channel blocker (eg, <a href=\"topic.htm?path=diltiazem-drug-information\" class=\"drug drug_general\">diltiazem</a> 180 to 240 <span class=\"nowrap\">mg/day)</span>. In patients whose primary symptom is chest pain, we suggest a calcium channel blocker or a tricyclic antidepressant (eg, <a href=\"topic.htm?path=imipramine-drug-information\" class=\"drug drug_general\">imipramine</a> 25 to 50 mg at bedtime) as the initial treatment.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A randomized trial found that <a href=\"topic.htm?path=diltiazem-drug-information\" class=\"drug drug_general\">diltiazem</a> (60 to 90 mg four times daily) significantly relieved chest pain as compared with placebo in 22 patients with nutcracker esophagus [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/27\" class=\"abstract_t\">27</a>]. In another study that included eight patients with DES, diltiazem led to a reduction in dysphagia as well as chest pain, although this difference was not statistically significant, possibly due to the small number of patients [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/28\" class=\"abstract_t\">28</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Two tricyclic antidepressants (TCAs), <a href=\"topic.htm?path=trazodone-drug-information\" class=\"drug drug_general\">trazodone</a> (100 to 150 <span class=\"nowrap\">mg/day)</span> and <a href=\"topic.htm?path=imipramine-drug-information\" class=\"drug drug_general\">imipramine</a> (50 <span class=\"nowrap\">mg/day),</span> have been shown to be effective in small randomized trials in relieving chest pain in patients with esophageal motility abnormalities [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/29,30\" class=\"abstract_t\">29,30</a>]. These results are likely due to the effect of TCAs on visceral sensory perception as TCAs have not been demonstrated to improve dysmotility [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/26\" class=\"abstract_t\">26</a>].</p><p/><p class=\"headingAnchor\" id=\"H2188832199\"><span class=\"h2\">Subsequent therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For patients who do not respond to initial treatment, treatment options include botulinum toxin or a nitric oxide contributing drug (eg, isosorbide 10 mg or <a href=\"topic.htm?path=sildenafil-drug-information\" class=\"drug drug_general\">sildenafil</a> 50 mg on an as needed basis for pain) [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/8,10,11,23,31,32\" class=\"abstract_t\">8,10,11,23,31,32</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a randomized trial, 22 patients with nutcracker esophagus or DES were assigned to treatment with botulinum toxin or saline injected endoscopically, 2 and 7 cm above the esophagogastric junction. Treatment with botulinum toxin, but not placebo, resulted in significant relief in dysphagia, but not chest pain, regurgitation, or heartburn [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/33\" class=\"abstract_t\">33</a>]. Other than reduction in esophagogastric junction resting pressure after botulinum toxin injection, there was no change in other manometric findings. Other disadvantages of botulinum toxin injection are the need for upper endoscopy and the limited duration of symptom relief (approximately six months) [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/32\" class=\"abstract_t\">32</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In one series of 11 patients with nutcracker esophagus or DES, <a href=\"topic.htm?path=sildenafil-drug-information\" class=\"drug drug_general\">sildenafil</a> (50 mg once daily as needed) was associated with symptom relief in four patients, of which two discontinued treatment due to associated side effects [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/34\" class=\"abstract_t\">34</a>].</p><p/><p class=\"headingAnchor\" id=\"H2188831958\"><span class=\"h2\">Other</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are limited data to support the use of other therapies in patients with DES, nutcracker esophagus, or hypertensive LES [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/11,35-37\" class=\"abstract_t\">11,35-37</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peroral endoscopic myotomy has demonstrated short-term relief in patients with nutcracker esophagus and DES. However, given the absence of randomized trials, long-term follow-up data, and potential complications (eg, postoperative dysphagia or reflux), myotomy cannot be recommended [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/38,39\" class=\"abstract_t\">38,39</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peppermint oil improved manometric abnormalities in a case series of eight patients with DES [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/37\" class=\"abstract_t\">37</a>]. Two patients also had improvement in chest pain. The clinical significance of these observations remains to be determined. In the author's experience, high concentration of peppermint oil (eg, sublingual Altoids on an as needed basis) may provide relief for attacks of DES-related chest pain.</p><p/><p class=\"headingAnchor\" id=\"H10098002\"><span class=\"h1\">PROGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Limited data suggest that over time, many patients with diffuse (distal) esophageal spasm (DES) will show symptomatic improvement [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/40\" class=\"abstract_t\">40</a>]. Some studies also suggest that manometric findings may change over time [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/41,42\" class=\"abstract_t\">41,42</a>]. Whether this variability is due to changes in esophageal motility over time or instead reflects the limitations of esophageal manometry is not clear. Approximately 5 percent of patients with DES subsequently develop achalasia that manifests as worsening dysphagia and regurgitation [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/43\" class=\"abstract_t\">43</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Esophageal motility is considered abnormal if motility findings exceed two standard deviations from those found in a large group of normal subjects [<a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/1\" class=\"abstract_t\">1</a>]. While the clinical implications of some esophageal motility disorders such as achalasia are clear, there is considerable controversy concerning the clinical significance of other abnormal esophageal motility patterns found on esophageal manometry testing and whether they cause or explain a patient's symptoms. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Esophageal motility disorders may occur as isolated phenomena (primary) or associated with other diseases (secondary) (<a href=\"image.htm?imageKey=GAST%2F64858\" class=\"graphic graphic_table graphicRef64858 \">table 1</a> and <a href=\"image.htm?imageKey=GAST%2F75807\" class=\"graphic graphic_table graphicRef75807 \">table 2</a>). Using conventional manometry, primary esophageal abnormalities are classified as achalasia and other abnormal motility patterns and further subclassified into those with hypercontracting, hypocontracting, or discoordinated motility. (See <a href=\"#H2\" class=\"local\">'Classification'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with diffuse (distal) esophageal spasm (DES) are usually symptomatic and present with dysphagia for solids and liquids, retrosternal chest pain, heartburn, or regurgitation. In contrast, most patients with hypertensive peristalsis (nutcracker esophagus) and hypertensive lower esophageal sphincter (LES) are asymptomatic. In all three disorders, the symptoms do not necessarily correlate with manometric abnormalities and are more likely due to concurrent gastroesophageal reflux disease (GERD) or heightened visceral sensitivity. (See <a href=\"#H3\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An esophageal motility disorder should be suspected in a patient with esophageal dysphagia, noncardiac chest pain, or refractory GERD symptoms (heartburn or regurgitation). The diagnosis of DES, nutcracker esophagus, and hypertensive LES requires the exclusion of other, more common conditions associated with these symptoms and the presence of characteristic abnormalities on esophageal manometry testing.</p><p/><p class=\"bulletIndent1\">In patients with esophageal dysphagia, we perform an upper endoscopy and biopsy to rule out other structural esophageal disorders. In patients with noncardiac chest pain or GERD symptoms (heartburn or regurgitation) that are refractory to twice daily proton pump inhibitor (PPI) therapy, we perform esophageal pH and impedance testing. If the above evaluation is negative, we then proceed to esophageal manometry testing to establish the diagnosis of a specific esophageal motility disorder (<a href=\"image.htm?imageKey=GAST%2F81108\" class=\"graphic graphic_algorithm graphicRef81108 \">algorithm 1</a> and <a href=\"image.htm?imageKey=GAST%2F66387\" class=\"graphic graphic_algorithm graphicRef66387 \">algorithm 2</a> and <a href=\"image.htm?imageKey=GAST%2F70106\" class=\"graphic graphic_algorithm graphicRef70106 \">algorithm 3</a>). (See <a href=\"#H2107332911\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>On conventional manometry testing, DES is characterized by 20 percent or more simultaneous contractions (with amplitude &gt;30 mmHg). Nutcracker esophagus is characterized by average peristaltic pressures exceeding 220 mmHg during 10 5 mL liquid swallows. Hypertensive LES is characterized by a resting lower esophageal pressure above 45 mmHg using conventional manometry or greater than 35 mmHg on high resolution esophageal pressure tomography (<a href=\"image.htm?imageKey=GAST%2F59779\" class=\"graphic graphic_table graphicRef59779 \">table 4</a>). (See <a href=\"#H6\" class=\"local\">'Esophageal manometry'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There are limited data to guide the management of symptomatic patients with manometric profiles of DES, nutcracker esophagus, or hypertensive LES.</p><p/><p class=\"bulletIndent1\">In patients whose primary symptom is chest pain, we suggest a calcium channel blocker (<a href=\"topic.htm?path=diltiazem-drug-information\" class=\"drug drug_general\">diltiazem</a> 180 to 240 <span class=\"nowrap\">mg/day)</span> or a tricyclic antidepressant (TCA; ie, <a href=\"topic.htm?path=imipramine-drug-information\" class=\"drug drug_general\">imipramine</a> 25 to 50 mg at bedtime) as the initial treatment (<a href=\"grade.htm?i=5\" class=\"grade\">Grade 2B</a>). In patients whose primary symptom is dysphagia, we suggest treatment with a calcium channel blocker (diltiazem 180 to 240 <span class=\"nowrap\">mg/day)</span> (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). We reserve the use of botulinum toxin or a nitric oxide contributing drug (eg, isosorbide 10 mg or <a href=\"topic.htm?path=sildenafil-drug-information\" class=\"drug drug_general\">sildenafil</a> 50 mg on an &quot;as needed&quot; basis for pain) for patients who do not respond to initial treatment. (See <a href=\"#H10\" class=\"local\">'Management'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/1\" class=\"nounderline abstract_t\">Richter JE, Wu WC, Johns DN, et al. Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of &quot;abnormal&quot; contractions. Dig Dis Sci 1987; 32:583.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/2\" class=\"nounderline abstract_t\">Kahrilas PJ. Esophageal motor disorders in terms of high-resolution esophageal pressure topography: what has changed? Am J Gastroenterol 2010; 105:981.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/3\" class=\"nounderline abstract_t\">Pandolfino JE, Ghosh SK, Rice J, et al. Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol 2008; 103:27.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/4\" class=\"nounderline abstract_t\">Kahrilas PJ, Ghosh SK, Pandolfino JE. Esophageal motility disorders in terms of pressure topography: the Chicago Classification. J Clin Gastroenterol 2008; 42:627.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/5\" class=\"nounderline abstract_t\">Dalton CB, Castell DO, Hewson EG, et al. Diffuse esophageal spasm. A rare motility disorder not characterized by high-amplitude contractions. Dig Dis Sci 1991; 36:1025.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/6\" class=\"nounderline abstract_t\">Katz PO, Dalton CB, Richter JE, et al. Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients. Ann Intern Med 1987; 106:593.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/7\" class=\"nounderline abstract_t\">Song CW, Lee SJ, Jeen YT, et al. Inconsistent association of esophageal symptoms, psychometric abnormalities and dysmotility. Am J Gastroenterol 2001; 96:2312.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/8\" class=\"nounderline abstract_t\">Agrawal A, Tutuian R, Hila A, Castell DO. Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility: a case report. Dig Dis Sci 2005; 50:2059.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/9\" class=\"nounderline abstract_t\">Konturek JW, Gillessen A, Domschke W. Diffuse esophageal spasm: a malfunction that involves nitric oxide? Scand J Gastroenterol 1995; 30:1041.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/10\" class=\"nounderline abstract_t\">Orlando RC, Bozymski EM. Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm. N Engl J Med 1973; 289:23.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/11\" class=\"nounderline abstract_t\">Swamy N. Esophageal spasm: clinical and manometric response to nitroglycerine and long acting nitrites. Gastroenterology 1977; 72:23.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/12\" class=\"nounderline abstract_t\">Murray JA, Ledlow A, Launspach J, et al. The effects of recombinant human hemoglobin on esophageal motor functions in humans. Gastroenterology 1995; 109:1241.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/13\" class=\"nounderline abstract_t\">Jung HY, Puckett JL, Bhalla V, et al. Asynchrony between the circular and the longitudinal muscle contraction in patients with nutcracker esophagus. Gastroenterology 2005; 128:1179.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/14\" class=\"nounderline abstract_t\">Korsapati H, Bhargava V, Mittal RK. Reversal of asynchrony between circular and longitudinal muscle contraction in nutcracker esophagus by atropine. Gastroenterology 2008; 135:796.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/15\" class=\"nounderline abstract_t\">Eypasch EP, Stein HJ, DeMeester TR, et al. A new technique to define and clarify esophageal motor disorders. Am J Surg 1990; 159:144.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/16\" class=\"nounderline abstract_t\">Agrawal A, Hila A, Tutuian R, et al. Clinical relevance of the nutcracker esophagus: suggested revision of criteria for diagnosis. J Clin Gastroenterol 2006; 40:504.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/17\" class=\"nounderline abstract_t\">Mujica VR, Mudipalli RS, Rao SS. Pathophysiology of chest pain in patients with nutcracker esophagus. Am J Gastroenterol 2001; 96:1371.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/18\" class=\"nounderline abstract_t\">Smout AJ, Breedijk M, van der Zouw C, Akkermans LM. Physiological gastroesophageal reflux and esophageal motor activity studied with a new system for 24-hour recording and automated analysis. Dig Dis Sci 1989; 34:372.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/19\" class=\"nounderline abstract_t\">Almansa C, Heckman MG, DeVault KR, et al. Esophageal spasm: demographic, clinical, radiographic, and manometric features in 108 patients. Dis Esophagus 2012; 25:214.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/20\" class=\"nounderline abstract_t\">CREAMER B, DONOGHUE E, CODE CF. Pattern of esophageal motility in diffuse spasm. Gastroenterology 1958; 34:782.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/21\" class=\"nounderline abstract_t\">Richter JE, Castell DO. Diffuse esophageal spasm: a reappraisal. Ann Intern Med 1984; 100:242.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/22\" class=\"nounderline abstract_t\">DiMarino AJ Jr. Characteristics of lower esophageal sphincter function in symptomatic diffuse esophageal spasm. Gastroenterology 1974; 66:1.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/23\" class=\"nounderline abstract_t\">Miller LS, Parkman HP, Schiano TD, et al. Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Dig Dis Sci 1996; 41:2025.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/24\" class=\"nounderline abstract_t\">Campo S, Traube M. Lower esophageal sphincter dysfunction in diffuse esophageal spasm. Am J Gastroenterol 1989; 84:928.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/25\" class=\"nounderline abstract_t\">Allen ML, DiMarino AJ Jr. Manometric diagnosis of diffuse esophageal spasm. Dig Dis Sci 1996; 41:1346.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/26\" class=\"nounderline abstract_t\">Tutuian R, Mainie I, Agrawal A, et al. Symptom and function heterogenicity among patients with distal esophageal spasm: studies using combined impedance-manometry. Am J Gastroenterol 2006; 101:464.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/27\" class=\"nounderline abstract_t\">Cattau EL Jr, Castell DO, Johnson DA, et al. Diltiazem therapy for symptoms associated with nutcracker esophagus. Am J Gastroenterol 1991; 86:272.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/28\" class=\"nounderline abstract_t\">Drenth JP, Bos LP, Engels LG. Efficacy of diltiazem in the treatment of diffuse oesophageal spasm. Aliment Pharmacol Ther 1990; 4:411.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/29\" class=\"nounderline abstract_t\">Clouse RE, Lustman PJ, Eckert TC, et al. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial. Gastroenterology 1987; 92:1027.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/30\" class=\"nounderline abstract_t\">Cannon RO 3rd, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994; 330:1411.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/31\" class=\"nounderline abstract_t\">Storr M, Allescher HD, R&ouml;sch T, et al. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointest Endosc 2001; 54:754.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/32\" class=\"nounderline abstract_t\">Miller LS, Pullela SV, Parkman HP, et al. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol 2002; 97:1640.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/33\" class=\"nounderline abstract_t\">Vanuytsel T, Bisschops R, Farr&eacute; R, et al. Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol 2013; 11:1115.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/34\" class=\"nounderline abstract_t\">Eherer AJ, Schwetz I, Hammer HF, et al. Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 2002; 50:758.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/35\" class=\"nounderline abstract_t\">Waterman DC, Dalton CB, Ott DJ, et al. Hypertensive lower esophageal sphincter: what does it mean? J Clin Gastroenterol 1989; 11:139.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/36\" class=\"nounderline abstract_t\">Triadafilopoulos G, Tsang HP, Segall GM. Hot water swallows improve symptoms and accelerate esophageal clearance in esophageal motility disorders. J Clin Gastroenterol 1998; 26:239.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/37\" class=\"nounderline abstract_t\">Pimentel M, Bonorris GG, Chow EJ, Lin HC. Peppermint oil improves the manometric findings in diffuse esophageal spasm. J Clin Gastroenterol 2001; 33:27.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/38\" class=\"nounderline abstract_t\">Khashab MA, Saxena P, Kumbhari V, et al. Peroral endoscopic myotomy as a platform for the treatment of spastic esophageal disorders refractory to medical therapy (with video). Gastrointest Endosc 2014; 79:136.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/39\" class=\"nounderline abstract_t\">Stein HJ, DeMeester TR. Therapy of noncardiac chest pain: is there a role for surgery? Am J Med 1992; 92:122S.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/40\" class=\"nounderline abstract_t\">Spencer HL, Smith L, Riley SA. A questionnaire study to assess long-term outcome in patients with abnormal esophageal manometry. Dysphagia 2006; 21:149.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/41\" class=\"nounderline abstract_t\">Khatami SS, Khandwala F, Shay SS, Vaezi MF. Does diffuse esophageal spasm progress to achalasia? A prospective cohort study. Dig Dis Sci 2005; 50:1605.</a></li><li><a href=\"https://www.uptodate.com/contents/esophageal-motility-disorders-clinical-manifestations-diagnosis-and-management/abstract/42\" class=\"nounderline abstract_t\">Dalton CB, Castell DO, Richter JE. The changing faces of the nutcracker esophagus. Am J Gastroenterol 1988; 83:623.</a></li><li class=\"breakAll\">http://www.nature.com/gimo/contents/pt1/full/gimo20.html (Accessed on October 09, 2014).</li></ol></div><div id=\"topicVersionRevision\">Topic 2256 Version 18.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H11\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">CLASSIFICATION</a></li><li><a href=\"#H2107334865\" id=\"outline-link-H2107334865\">EPIDEMIOLOGY</a></li><li><a href=\"#H2107333572\" id=\"outline-link-H2107333572\">PATHOPHYSIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CLINICAL FEATURES</a><ul><li><a href=\"#H2107334765\" id=\"outline-link-H2107334765\">Clinical manifestations</a></li><li><a href=\"#H2107333021\" id=\"outline-link-H2107333021\">Imaging findings</a></li></ul></li><li><a href=\"#H2107332911\" id=\"outline-link-H2107332911\">DIAGNOSIS</a><ul><li><a href=\"#H26371848\" id=\"outline-link-H26371848\">Diagnostic approach</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Esophageal manometry</a><ul><li><a href=\"#H2107333199\" id=\"outline-link-H2107333199\">- Diffuse (distal) esophageal spasm</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- Hypertensive peristalsis (nutcracker esophagus)</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">- Hypertensive lower esophageal sphincter</a></li></ul></li></ul></li><li><a href=\"#H2188832589\" id=\"outline-link-H2188832589\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">MANAGEMENT</a><ul><li><a href=\"#H2188831933\" id=\"outline-link-H2188831933\">Initial therapy</a></li><li><a href=\"#H2188832199\" id=\"outline-link-H2188832199\">Subsequent therapy</a></li><li><a href=\"#H2188831958\" id=\"outline-link-H2188831958\">Other</a></li></ul></li><li><a href=\"#H10098002\" id=\"outline-link-H10098002\">PROGNOSIS</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/2256|ALG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"ALGORITHMS\">ALGORITHMS</a></div><ul><li><a href=\"image.htm?imageKey=GAST/81108\" class=\"graphic graphic_algorithm\">- Diagnosis esophageal dysphagia</a></li><li><a href=\"image.htm?imageKey=GAST/66387\" class=\"graphic graphic_algorithm\">- Dx esophageal chest pain</a></li><li><a href=\"image.htm?imageKey=GAST/70106\" class=\"graphic graphic_algorithm\">- Management algorithm of GERD patient who failed PPI once daily</a></li></ul></li><li><div id=\"GAST/2256|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/69821\" class=\"graphic graphic_diagnosticimage\">- Diffuse esophageal spasm barium swallow</a></li><li><a href=\"image.htm?imageKey=RADIOL/93739\" class=\"graphic graphic_diagnosticimage\">- Barium swallow DES corkscrew esophagus</a></li></ul></li><li><div id=\"GAST/2256|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/82704\" class=\"graphic graphic_figure\">- Diffuse esophageal spasm HREPT and manometry</a></li><li><a href=\"image.htm?imageKey=GAST/67976\" class=\"graphic graphic_figure\">- Nutcracker esophagus HREPT and manometry</a></li></ul></li><li><div id=\"GAST/2256|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/64858\" class=\"graphic graphic_table\">- Classification of primary esophageal motility abnormalities</a></li><li><a href=\"image.htm?imageKey=GAST/75807\" class=\"graphic graphic_table\">- Classification of secondary esophageal motility abnormalities</a></li><li><a href=\"image.htm?imageKey=GAST/81969\" class=\"graphic graphic_table\">- Comparison of esophageal motility findings</a></li><li><a href=\"image.htm?imageKey=GAST/59779\" class=\"graphic graphic_table\">- The Chicago Classification of esophageal motility</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=achalasia-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Achalasia: Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-evaluation-of-dysphagia-in-adults\" class=\"medical medical_review\">Approach to the evaluation of dysphagia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=esophageal-multichannel-intraluminal-impedance-testing\" class=\"medical medical_review\">Esophageal multichannel intraluminal impedance testing</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-the-adult-with-chest-pain-of-esophageal-origin\" class=\"medical medical_review\">Evaluation of the adult with chest pain of esophageal origin</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=high-resolution-manometry\" class=\"medical medical_review\">High resolution manometry</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-treatment-of-achalasia\" class=\"medical medical_review\">Overview of the treatment of achalasia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathophysiology-and-etiology-of-achalasia\" class=\"medical medical_review\">Pathophysiology and etiology of achalasia</a></li></ul></div></div>","javascript":null}